Navigation Links
Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
Date:9/6/2007

and are essential for the pollination of more than 90 fruit and vegetable crops worldwide. The economic value of these agricultural products is placed at more than $14.6 billion in the United States alone. In CCD, honeybee colonies inexplicably lose all of their worker bees. CCD has resulted in a loss of 50% to 90% of colonies in beekeeping operations across the United States. The observation that irradiated honeycombs from affected colonies could be repopulated with healthy bees, while non-sterilized combs could not, suggested an infectious basis for CCD. Suspected pathogens were screened for association with CCD by examination of samples collected from several sites over a period of three years.

"We are very pleased to see our technology applied to solve real-world problems. We are hopeful this latest research will help eliminate the threat of CCD to global agriculture" said Christopher McLeod, president of 454 Life Sciences. "The chief advantage of 454 Sequencing technology is how it quickly

enables researchers to identify the organisms present in complex environments without any advance knowledge of the sample."

CCD was first reported in the fall of 2006 in the Unites States. Since then, CCD has been reported in Germany, Switzerland, Spain, Portugal, Italy and Greece. A recent survey of 13 states by the Apiary Inspectors of America showed that over a quarter of U.S. beekeepers have lost, on average, half of their bee colonies between September 2006 and March 2007.

454 Life Sciences develops and commercializes novel instrumentation for high-throughput DNA sequencing. Specific applications include whole-genome sequencing, RNA analysis and ultra-deep sequencing of target genes. The hallmarks of 454 Sequencing(TM) are its simple, unbiased sample preparation and massively parallel sequencing, which makes large-scale scientific projects feasible and more affordable. During the last months, the technology proved its suitability in a lot of appli
'/>"/>

SOURCE 454 Life Sciences
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Stanford Researchers Find Brain Pathway of Depression in Rats
3. Researchers Discover Method for Identifying How Cancer Evades the Immune System
4. Researchers Discover Gene For Rare Skin Disorder
5. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
6. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
7. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
8. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
9. World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester
10. Researchers Urge Caution in Using ESAs for Cancer-Related Anemia
11. Researchers Identify New Genetic Risk Factors for Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... AUSTIN, Texas , March 30, 2015 ... highlight the My Diabetes Emergency Plan at the 2015 ... encourage you to be prepared to manage your #diabetes ... of Endocrinology (ACE) – the charitable, educational and scientific ... – has joined forces with Lilly Diabetes to share ...
(Date:3/30/2015)... , March 30, 2015  Check-Cap Ltd. (NASDAQ: ... focused on the development of a preparation-free ingestible imaging ... colorectal cancer, announced today that its CEO, Guy Neev ... 31, 2015 trading day.  Neev and Check-Cap will participate ... the company,s initial public offering and simultaneous private placement ...
(Date:3/30/2015)... March 30, 2015  Uroplasty, Inc. (NASDAQ: UPI ... shareholders have voted at the special meeting of ... previously announced agreement and plan of merger between ... with the outcome of today,s special meetings, and ... for approving the merger agreement," said Rob ...
Breaking Medicine Technology:Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4
... Pa., May 25, 2011 A study titled ... published in the May 26 issue of ... prostate cancer who have received prior chemotherapy containing ... when treated with ZYTIGA ™ (abiraterone acetate) ...
... (NASDAQ: ITMN ) will outline the company,s corporate ... ongoing plans to commercialize Esbriet ® (pirfenidone) in Europe, ... pirfenidone study, during a meeting with analysts in New York ... the presentations beginning at 8:30 a.m. EDT.   ...
Cached Medicine Technology:Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 2Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 3Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 4Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 5Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 6InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 2InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 3InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 4InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 5InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study 6
(Date:3/30/2015)... Dr. Jeffrey Allred DDS, with his practice ... second opinion consultations for patients who need a ... dental second opinions show how small percentage of dentistry patients ... Only 6%” – says Dr. Allred. , “People should ... trusting the dental care provider, for the simple fact that ...
(Date:3/30/2015)... Birmingham, AL (PRWEB) March 30, 2015 ... medical malpractice and defective medical devices, has filed a ... Alabama family whose baby died following his premature birth ... Mobile County Circuit Court, alleges that the Mirena IUD ... strings, which also made the device difficult to remove. ...
(Date:3/30/2015)... 30, 2015 “ iCareTech ” was featured ... takes a look at the latest and coolest technology products ... reporter and technology expert, conducted the review and shared with ... dedicated to the medical and health fields. , Wearable technology ... over the past couple of years. Well, at CES, NewsWatch ...
(Date:3/30/2015)... According to a recently published report by iData ... continue to dominate the European soft tissue reinforcement and ... numbers of ventral hernias, and the adoption of expensive ... market share represented by ventral hernia repair devices is ... growing use of expensive biologics,” explains Dr. Kamran Zamanian, ...
(Date:3/30/2015)... March 30, 2015 Follow us ... efforts to develop and establish chronic pain rehabilitation centers ... in the market is poised to benefit from the ... of the increase in chronic health conditions such as ... arthritis, among others. While conventional treatment for pain management ...
Breaking Medicine News(10 mins):Health News:Allred Dental Offers Complimentary 15 Minute Consults with Dr. Jeffrey Allred in San Marcos, CA 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 3Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 4Health News:World’s First Medical Intelligent Band was Featured on NewsWatch Television on January 30, 2015 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 3Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3
... 19 Statement by Chris,Cathcart, President, CSPA: "The ... report issued by the Natural Resources,Defense Council (NRDC) ... air,freshener products. NRDC,s report appears to be based ... each of 14 air freshener products. As a,result, ...
... September, 2007 The decline in cervical ... there are reasons to be optimistic about even further ... women who are not screened. A meta-analysis by Spence ... Preventive Medicine shows that undergoing Pap smears irregularly or ...
... University School of Medicine (BUSM), Boston University School ... Lung and Blood Institute (NHLBI), have completed analyses ... two generations of participants from the landmark Framingham ... genetic differences that potentially affect the risk for ...
... peripheral artery disease , , WEDNESDAY, Sept. 19 (HealthDay ... tickling America,s funny bone and tugging at its ... working for now, crisscrossing the country to raise ... cardiovascular threat called peripheral artery disease (PAD). , ...
... Reserve Grand Champion Pair Of Cattle Comes From Binson,s ... Home Health Care Centers, Donation Of Food And Funds Continues Longstanding ... ... homeless and working poor will be among those to benefit from a,generous gift from Binson,s ...
... to end insurance ... pass S.558, ALEXANDRIA, Va., Sept. 18 Mental ... legislation,today to end mental health insurance discrimination, and its ... Edward,Kennedy (D-Mass.) for their leadership. The bill -- S. ...
Cached Medicine News:Health News:Consumer Specialty Products Association Highly Critical of NRDC Study on Home Air Fresheners 2Health News:Cervical cancer screening: Too many are left unprotected 2Health News:Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits 2Health News:Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits 3Health News:'Cosby' Star Tackles a Silent Heart Threat 2Health News:'Cosby' Star Tackles a Silent Heart Threat 3Health News:'Cosby' Star Tackles a Silent Heart Threat 4Health News:$8,000 Winning Bids at Governor's Livestock Auction to Benefit College-Bound Youth and Homeless 2Health News:Senate Passes 'Mental Health Parity' 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: